APP and Alzheimer disease: In summary, we demonstrated that 16 weeks Lf intervention had no effect on cognitive function, and key AD related markers including Aβ, tau pathology, neuro-inflammation, and synaptic plasticity from both the young and middle-aged APP/PS1 mice; while Lf differentially affected gut microbiota profiles.